Vigmed Holding AB (publ) reschedules interim report

The Board of Directors of Vigmed Holding AB (publ) has decided to reschedule the
publication of the interim report for January - September 2016. The company will
publish the report on November 15, 2016.
The Board of Directors of Vigmed Holding AB (publ) has decided to reschedule the
publication of the interim report for January - September 2016. The company will
publish the report on November 15, 2016.
For further information contact:

Chairman of the board, Sten Dahlborg + 70 836 9419 or CEO, Henrik Olsen +46 76
349 7364
Vigmed is a Swedish medical technology company whose mission is to eliminate
needlestick injuries and the associated risk of cross infections with blood
-borne infectious diseases by offering the market unique needle-protected
products. Vigmed is headquartered in Helsingborg, Sweden. Vigmed’s share is
traded on NASDAQ OMX First North in Stockholm (ticker VIG) and has
approximately 5 600 shareholders. Remium Nordic AB is the Company’s Certified
Advisor. Additional information about the company can be found on Vigmed’s
website: www.vigmed.com/investor